4don MSN
Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, ...
Novo Nordisk (NVO) shares gain after the pharmaceutical company's earnings beat on the bottom and top lines despite warnings ...
Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Novo Nordisk shares tumbled last year when obesity candidate CagriSema failed to clear a weight loss bar of 25%. Now, ...
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...
Novo Nordisk’s CEO Lars Fruergaard Jorgensen said the company “remains confident in [CagriSema’s] potent biology and looks forward to further exploring its potential and to making it ...
Novo Nordisk (NVO) stock and Eli Lilly (LLY) stock higher as Novo (NVO) reports strong Q4 2024 earnings, driven by sales ...
STORY HIGHLIGHTS Novo Nordisk plans $4.1 billion expansion in Clayton, creating 1,000 jobs. CEO Lars Fruergaard Jørgensen believes potential tariffs can be handled. Analysts expect minimal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback